Mary Kay Fenton
2011 - Achillion Pharmaceuticals
In 2011, Mary Kay Fenton earned a total compensation of $817.6K as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $105,676 |
|---|---|
| Option Awards | $416,633 |
| Salary | $287,625 |
| Other | $7,703 |
| Total | $817,637 |
Fenton received $416.6K in option awards, accounting for 51% of the total pay in 2011.
Fenton also received $105.7K in non-equity incentive plan, $287.6K in salary and $7.7K in other compensation.
Rankings
In 2011, Mary Kay Fenton's compensation ranked 6,380th out of 10,747 executives tracked by ExecPay. In other words, Fenton earned more than 40.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,380 out of 10,747 | 41st |
Division Manufacturing | 2,309 out of 3,960 | 42nd |
Major group Chemicals And Allied Products | 531 out of 1,033 | 49th |
Industry group Drugs | 351 out of 781 | 55th |
Industry Pharmaceutical Preparations | 278 out of 571 | 51st |
Source: SEC filing on April 18, 2014.
Fenton's colleagues
We found five more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2011.
2011
Michael Kishbauch
Achillion Pharmaceuticals
Chief Executive Officer
2011
Elizabeth Olek
Achillion Pharmaceuticals
Chief Medical Officer
2011
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
2011
Joseph Truitt
Achillion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2011
Gautam Shah
Achillion Pharmaceuticals